Outcome | PRP + Artz (N = 48) | PRP + HYAJOINT Plus (N = 47) | A.M.D. (95% C.I.) | P valueb |
---|---|---|---|---|
WOMAC-pain Baseline | 5.9 ± 3.8 | 6.0 ± 3.2 | −0.1a (−1.5, 1.4) | 0.909 t |
1 month | 3.3 ± 3.1 | 3.9 ± 2.8 | − 0.6 (− 1.6, 0.4) | 0.242 |
3 month | 3.4 ± 3.5 | 3.2 ± 2.1 |  | Fig. 2a (B > 8.5,Plus<Artz) |
6 month | 3.2 ± 3.2 | 3.9 ± 2.8 | −0.6 (−1.6, 0.4) | 0.260 |
P Valuec (post hoc test) | < 0.001* (B > 1 M; B > 3 M; B > 6 M) | < 0.001* (B > 1 M;B > 3 M; B > 6 M) |  | 0.599a |
WOMAC-stiffness Baseline | 2.6 ± 1.7 | 2.3 ± 1.3 | 0.2a (−0.4, 0.9) | 0.424t |
1 month | 1.5 ± 1.4 | 1.6 ± 1.1 | −0.3 (− 0.7, 0.2) | 0.307 |
3 month | 1.5 ± 1.6 | 1.3 ± 1.1 | 0.05 (−0.4, 0.5) | 0.823 |
6 month | 1.3 ± 1.4 | 1.8 ± 1.1 | −0.6 (− 0.1, −1.0) | 0.020* |
P Valuec (post hoc test) | < 0.001* (B > 1 M; B > 3 M; B > 6 M) | < 0.001* (B > 1 M; B > 3 M) |  |  |
WOMAC-function Baseline | 19.7 ± 13.5 | 21.0 ± 11.9 | −1.3a (−6.4, 3.9) | 0.634 t |
1 month | 11.5 ± 10.9 | 14.2 ± 9.2 | −2.2 (−5.7, 1.3) | 0.215 |
3 month | 12.6 ± 12.4 | 10.7 ± 8.5 |  | Fig. 2b (B > 21.7, Plus<Artz) |
6 month | 11.8 ± 11.2 | 13.9 ± 11.2 | −1.4 (−5.0, 2.2) | 0.438 |
P Valuec (post hoc test) | < 0.001* (B > 1 M; B > 3 M;B > 6 M) | < 0.001* (B > 1 M; B > 3 M;B > 6 M; 1 M > 3 M) |  |  |
WOMAC-total Baseline | 28.2 ± 18.4 | 29.3 ± 15.6 | −1.1a (−8.1, 5.9) | 0.757 t |
1 month | 16.2 ± 15.1 | 19.8 ± 12.3 | −3.1 (−7.8, 1.7) | 0.204 |
3 month | 17.6 ± 16.9 | 15.3 ± 11.0 |  | Fig. 2c (B > 32.0, Plus<Artz) |
6 month | 16.4 ± 15.5 | 19.5 ± 14.6 | −2.5 (−7.4, 2.3) | 0.304 |
P Valuec (post hoc test) | < 0.001* (B > 1 M; B > 3 M; B > 6 M) | < 0.001* (B > 1 M; B > 3 M; B > 6 M; 1 M > 3 M;6 M > 3 M) |  |  |